Literature DB >> 6143666

Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.

M M Kubik, J H Coote.   

Abstract

In a double blind, within patient investigation of twenty-four patients (nineteen males and five females) with a mean age of 46.3 years (SD 10.9 years) with mild to moderate essential hypertension a comparison between equipotent beta-blocking doses of propranolol, metoprolol and labetalol was carried out. Blood pressure and pulse rate were measured in lying, sitting and standing positions and before, during and after isometric and dynamic exercise. Peak expiratory flow was recorded before and during dynamic exercise. All the active treatments were better than placebo in reducing blood pressure and heart rate. Comparing the effects of treatment, labetalol lowered sitting diastolic pressure significantly more than propranolol and standing diastolic pressure than both propranolol and metoprolol. Metoprolol and propranolol were more effective in reducing heart rate. Propranolol significantly reduced peak flow rate compared to labetalol. During the exercise, both isometric and dynamic, the heart rate and the blood pressure, both systolic and diastolic, of the treated patients were lower than those on placebo. There was little difference between the drugs in the influence on blood pressure, but metoprolol and propranolol were significantly more effective than labetalol in lowering the heart rate.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6143666     DOI: 10.1007/bf00546699

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  21 in total

1.  Haemodynamic effects of beta-adrenorecptor blockers in hypertension.

Authors:  B Ablad; B Ljung; R Sannerstedt
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  Application of 'flow volume curves' to assess the selectivity of beta-adrenoceptor antagonist drugs.

Authors:  C R Kumana; R Ruffin
Journal:  Br J Clin Pharmacol       Date:  1978-06       Impact factor: 4.335

Review 3.  Effect of physical training on cardiovascular adjustments to exercise in man.

Authors:  J P Clausen
Journal:  Physiol Rev       Date:  1977-10       Impact factor: 37.312

Review 4.  Static (isometric) exercise and the heart: physiological and clinical considerations.

Authors:  J H Mitchell; K Wildenthal
Journal:  Annu Rev Med       Date:  1974       Impact factor: 13.739

Review 5.  Human cardiovascular adjustments to exercise and thermal stress.

Authors:  L B Rowell
Journal:  Physiol Rev       Date:  1974-01       Impact factor: 37.312

6.  Comparison of the antihypertensive effects of indapamide and metoprolol.

Authors:  M M Kubik; J H Coote
Journal:  Postgrad Med J       Date:  1981       Impact factor: 2.401

7.  Evaluation of a new automatic device for taking and recording blood pressures.

Authors:  S W Hoobler; B Oesterle; H Early
Journal:  J Lab Clin Med       Date:  1976-11

8.  Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.

Authors:  C L van Herwaarden; R A Binkhorst; J F Fennis; A van't Laar
Journal:  Br Heart J       Date:  1979-01

9.  Propranolol LA and ambulatory blood pressure.

Authors:  S Mann; M W Craig; V Balasubramanian; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

10.  Effect of labetalol in hypertension during exercise and postural changes.

Authors:  V Balasubramanian; S Mann; M W Millar-Craig; E B Raftery
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

View more
  6 in total

Review 1.  The applied pharmacology of beta-adrenoceptor antagonists (beta blockers) in relation to clinical outcomes.

Authors:  J D Fitzgerald
Journal:  Cardiovasc Drugs Ther       Date:  1991-06       Impact factor: 3.727

Review 2.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

3.  New drugs for the treatment of hypertension: where do they fit?

Authors:  T W Wilson; M P Dubois
Journal:  Can Fam Physician       Date:  1987-11       Impact factor: 3.275

Review 4.  Labetalol. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in hypertension and ischaemic heart disease.

Authors:  K L Goa; P Benfield; E M Sorkin
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

Review 5.  Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.

Authors:  R Donnelly; G J Macphee
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

Review 6.  Metoprolol. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in hypertension, ischaemic heart disease and related cardiovascular disorders.

Authors:  P Benfield; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.